상세 보기
Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) (2020)
- Cho, Jang Ho;
- Lim, Sung Hee;
- An, Ho Jung;
- Kim, Ki Hwan;
- Park, Keon Uk;
- ... Kang, Eun Joo;
- 외 8명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0초록
The February 10, 2020, article by Cho et al, entitled “Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)” (J Clin Oncol 10.1200/JCO.19.00931), was published with an error. © 2020 American Society of Clinical Oncology. All rights reserved.
- 제목
- Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) (2020)
- 저자
- Cho, Jang Ho; Lim, Sung Hee; An, Ho Jung; Kim, Ki Hwan; Park, Keon Uk; Kang, Eun Joo; Choi, Yoon Hee; Ahn, Mi Sun; Lee, Myung Hee; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju
- 발행일
- 2020-04
- 유형
- Correction
- 권
- 38
- 호
- 11
- 페이지
- 1248 ~ 1248
- 언어
- ENG
- 출판사
- American Society of Clinical Oncology
- 발행국가
- 미국
- 분량
- 1 페이지
- ISSN
- E 1527-7755
P 0732-183X